Articles with "alogliptin" as a keyword



Photo from wikipedia

Alogliptin alleviates liver fibrosis via suppression of activated hepatic stellate cell.

Sign Up to like & get
recommendations!
Published in 2019 at "Biochemical and biophysical research communications"

DOI: 10.1016/j.bbrc.2019.02.065

Abstract: Liver fibrosis occurs in most types of chronic liver diseases. The understanding of the pathogenesis of liver fibrosis has grown considerably, but the effective treatments are still lacking. Alogliptin, a classical Dipeptidyl peptidase-4 (DPP4) inhibitor… read more here.

Keywords: stellate cell; fibrosis; liver fibrosis; alogliptin ... See more keywords
Photo from wikipedia

The anti-diabetic drug alogliptin induces vasorelaxation via activation of Kv channels and SERCA pumps.

Sign Up to like & get
recommendations!
Published in 2021 at "European journal of pharmacology"

DOI: 10.1016/j.ejphar.2021.173991

Abstract: In the present study, we investigated the vasorelaxant effects of alogliptin, an oral antidiabetic drug in the dipeptidyl peptidase-4 (DPP-4) inhibitor class, using phenylephrine (Phe)-induced pre-contracted aortic rings. Alogliptin induced vasorelaxation in a dose-dependent manner.… read more here.

Keywords: channel inhibitor; inhibitor; vasorelaxation; alogliptin ... See more keywords
Photo from wikipedia

Alogliptin improves endothelial function by promoting autophagy in perivascular adipose tissue of obese mice through a GLP-1-dependent mechanism.

Sign Up to like & get
recommendations!
Published in 2019 at "Vascular pharmacology"

DOI: 10.1016/j.vph.2018.11.003

Abstract: OBJECTIVE Perivascular adipose tissue (PVAT) regulates vascular function in a paracrine manner and the vasodilatory effect of PVAT on vessels is completely abolished in obesity. In addition, autophagy is required for maintaining biological function of… read more here.

Keywords: alogliptin; endothelial function; obese mice; function ... See more keywords
Photo by susangkomen3day from unsplash

Alogliptin Induced Stomatitis: An Adverse Drug Event Case Report.

Sign Up to like & get
recommendations!
Published in 2022 at "Journal of pharmacy practice"

DOI: 10.1177/08971900221108721

Abstract: Background: Dipeptidyl peptidase (DPP)-4 inhibitors are commonly used agents to treat type 2 diabetes mellitus (T2DM). Although generally well tolerated, stomatitis has been previously reported as an adverse event with sitagliptin and linagliptin. Stomatitis with… read more here.

Keywords: alogliptin; event; stomatitis; report ... See more keywords
Photo from wikipedia

Alogliptin and Heart Failure Outcomes in Patients With Type 2 Diabetes.

Sign Up to like & get
recommendations!
Published in 2022 at "Journal of pharmacy practice"

DOI: 10.1177/08971900221135656

Abstract: Background: In 2016, the FDA issued a warning for saxagliptin and alogliptin regarding an increased risk of heart failure (HF), potentially limiting the use of effective medications in type 2 diabetes. Current data and guideline… read more here.

Keywords: alogliptin; heart failure; type diabetes; risk ... See more keywords
Photo from wikipedia

Alogliptin after acute coronary syndrome in patients with type 2 diabetes: a renal function stratified analysis of the EXAMINE trial

Sign Up to like & get
recommendations!
Published in 2020 at "BMC Medicine"

DOI: 10.1186/s12916-020-01616-8

Abstract: Background The EXAMINE trial tested the efficacy and safety of alogliptin, an inhibitor of dipeptidyl peptidase 4, compared with placebo in 5380 patients with type 2 diabetes and a recent acute coronary syndrome. Because alogliptin… read more here.

Keywords: alogliptin; egfr; patients type; type diabetes ... See more keywords
Photo by edhoradic from unsplash

Investigation of Alogliptin-Loaded In Situ Gel Implants by 23 Factorial Design with Glycemic Assessment in Rats

Sign Up to like & get
recommendations!
Published in 2022 at "Pharmaceutics"

DOI: 10.3390/pharmaceutics14091867

Abstract: The aim of the study was to design injectable long-acting poly (lactide-co-glycolide) (PLGA)-based in situ gel implants (ISGI) loaded with the anti-diabetic alogliptin. Providing sustained therapeutic exposures and improving the pharmacological responses of alogliptin were… read more here.

Keywords: factorial design; alogliptin; alogliptin loaded; situ gel ... See more keywords